Fresenius Medical Care | FME - Cost Of Sales


Fresenius Medical Care reported EUR3.43B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Akzo Nobel EUR 1.5B 95M Jun/2026
Alcon AG USD 1.18B 26M Mar/2026
AstraZeneca USD 2.52B 2.73B Jun/2026
Bayer EUR 5.23B 731M Mar/2026
Beiersdorf EUR 2.06B 50M Dec/2025
DaVita Healthcare Partners USD 2.52B 76.13M Mar/2026
Demant DKK 2.89B 188M Dec/2025
E.ON EUR 16.41B 114M Mar/2026
Essilor EUR 5.55B 505M Jun/2026
Fresenius EUR 4.4B 111M Jun/2026
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Genmab DKK 84M 19M Jun/2026
Getinge SEK 3.97B 2.05B Jun/2026
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 2.07B 192M Jun/2026
GN Store Nord DKK 1.16B 1.08B Mar/2026
GRIFOLS EUR 1.17B 90M Jun/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.07B 219M Mar/2026
Novartis USD 3.71B 251M Jun/2026
Philips EUR 2.21B 70M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
RWE EUR 3.21B 397M Mar/2026
Sanofi EUR 3.02B 656M Jun/2026
SAP EUR 2.65B 68M Jun/2026
Smith & Nephew USD 901M 31M Jun/2026